Titan Medical Inc (TMDIF)

[longtermgems]

Trxc wasn't the only company interested in buying Alf-X. According to SOFAR management, they wanted to sell to a company where ALF-X would be a meaningful source of revenue/growth and the company would be focused on success of selling alf-x rather than an already established multi billion $ company that wouldn't have as much on the line regarding the success of alf-x and would probably just want their patent portfolio at the very least. SOFaR believes TRxC will focus on making ALF-X a successful product rather than just scrapping it for parts (the patents), which is why SOFaR took 75% of the deal in stock and the stock is locked up/restricted from being sold for two years.

This is all explained in a BTIG analyst note by Sean Lavin who met with SOFaR insiders at a conference two months ago. I posted the note on this board and its posted online as well. You can also access the note yourself on the BtIG website just register with a financial institution email (I.e. [e-mail]).

The ALF-X is a serious competitor to ISRG da Vinci, not TITXF sport. The alf-x will cost $1.7M but per procedure costs will only be $600 rather than $3,000+ for da Vinci.